SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biogen
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
1686 75 0 BIIB
Emcee:  Harold Engstrom Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1061 ? ...hmmm, interesting answer. I guess you really didn't want a response JEB-6/20/1999
1060 The article only mentioned Avonex but no other future drugs were discussed. P.M.Freedman-6/20/1999
1059 A lot of the questions you asked this thread are answered here: go2net.newsaleJEB-6/20/1999
1058 *OT* GENZ chart shows a short term sell signal but the 3 month long term shows JEB-6/19/1999
1057 Wow Genz, I'll just run out and buy some. FirstBoston, after all, is at thWilliam Partmann-6/18/1999
1056 FirstBoston reiterates a buy for BGEN, but a strong buy for GENZ because they bP.M.Freedman-6/18/1999
1055 Repost of pretty good site to find rough idea of a company's pipeline: recHarold Engstrom-6/16/1999
1054 synchro--- Good post. Thank you. I really hope I don't sound like a BGEN bWalkingshadow-6/16/1999
1053 Biogen has one drug on the market with good earnings growth potential. Whethersynchro-6/15/1999
1052 Harold-- There are many effective medications (both oral and IV) already in usWalkingshadow-6/15/1999
1051 concerning adentri- one place to look may be the CV therapeutic homepage or lidmkst1-6/15/1999
1050 WS, Adentri is one of my many weakspots! I have a very superficial knowledge oHarold Engstrom-6/15/1999
1049 Harold-- Thanks for the post--good work! One question I have regards Adentri.Walkingshadow-6/15/1999
1048 "Amevive is likely to be the primary choice where there really aren't Dante Sinferno-6/13/1999
1047 Amevive - 2001 launch Antova - 2002 VLA4 - 2002/3 Adentri - 2003/4 Gelsolin - IHarold Engstrom-6/13/1999
1046 Harold--I like your list. What're the time frames for the candidate drugs P.M.Freedman-6/13/1999
1045 My current understanding of the state of Biogen's pipeline: 1. VLA4 (AsthmaHarold Engstrom-6/13/1999
1044 P.M. You have far too much information to be a casual daytrader. Let me see, oWilliam Partmann-6/13/1999
1043 Steve-- I agree that BGEN is definitely a potential candidate for my portfolioWalkingshadow-6/13/1999
1042 Vector-- Definitely food for thought. I would agree that timing is another impWalkingshadow-6/13/1999
1041 On the subject of pipelines the key issue is not number of candidates but likelVector1-6/13/1999
1040 WS: My quick post to summarize a few highlights of Friday's Biogen Annual SDR-SI-6/13/1999
1039 Bill--Another key issue to which you, as a long term investor, should pay attenP.M.Freedman-6/13/1999
1038 Steve-- If that's their philosophy, I'm warming to BGEN! I would much Walkingshadow-6/13/1999
1037 A funny site about treatment of psoriasis: marga.com Biogen's Amevive has tP.M.Freedman-6/13/1999
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News